Pharmaceutical company Eli Lilly And Co (LLY) is up 7.2% to $821.20 as President Trump imposes a 100% tariff on pharmaceutical products, exempting Eli Lilly due to a $27 billion U.S. expansion. The stock is boosted by the broader pharmaceutical sector and Pfizer’s deal with Trump.

LLY stock hits highest point since June, aiming for fourth consecutive win with best daily gain since April. Facing resistance at the 320-day moving average, the stock remains 7.1% lower year-over-year. Options trading shows high volume of calls compared to puts.

124,000 calls and 44,000 puts traded on Eli Lilly today, four times the average daily rate. Popular options include the weekly 10/3 800- and 820-strike calls, bought to open and expiring this Friday. The Schaeffer’s Volatility Index shows low volatility expectations in these bargain options.

Read more at Yahoo Finance: Another Surging Pharma Stock to Watch Right Now